Larsen & Toubro. CMP: INR1,160 TP: INR1,417 Buy

Similar documents
Larsen & Toubro. CMP: INR1,278 TP: INR1,380 Buy

BGR Energy. CMP: INR284 TP: INR296 Neutral

BGR Energy. CMP: INR266 TP: INR230 Neutral

BGR Energy. CMP: INR282 TP: INR253 Neutral

NTPC CMP: INR169 TP: INR191 Buy

Cummins India. CMP: INR430 TP: INR462 Neutral

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy

Pidilite Industries. CMP: INR164 TP: INR186 Buy

Titan Industries. CMP: INR222 TP: INR220 Neutral

Unitech. CMP: INR20 TP: INR30 Buy

Jaiprakash Associates

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

Canara Bank. CMP: INR419 TP: INR525 Buy

IndusInd Bank. CMP: INR345 TP: INR419 Buy

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral

IDBI Bank. CMP: INR106 TP: INR121 Neutral

Coal India CMP: INR348 TP: INR408 Buy

BHEL. CMP: INR227 TP: INR233 Neutral

Reliance Infrastructure CMP: INR528

CMP: INR121 TP: INR193 Buy

Hardick Bora

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

Godrej Consumer Products

Idea Cellular. CMP: INR81 TP: INR Under Review

Punjab National Bank. CMP: INR716 TP: INR950 Buy

Canara Bank. CMP: INR464 TP: INR645 Buy

Niket Shah

Sanjay Jain Pavas Pethia

Thermax. CMP: INR522 TP: INR414 Neutral

Godawari Power & Ispat

Jubilant Foodworks. CMP: INR1,051 TP: INR1,054 Neutral

CMP: INR350 TP: INR375 Downgrade to Neutral

Steel Authority of India

Petronet LNG. CMP: INR146 TP: INR205 Buy

Sohail Halai Alpesh Mehta

Punjab National Bank. CMP: INR768 TP: INR963 Buy

Monnet Ispat. CMP: INR449 TP: INR518 Neutral

Strides Arcolab. CMP: INR717 TP: INR829 Buy

Tata Power. CMP: INR111 TP: INR92 Neutral

Oberoi Realty. CMP: INR264 TP: INR315 Buy

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy

Shree Renuka Sugars. CMP: INR26 TP: INR45 Buy

Dabur India. CMP: INR106 TP: INR94 Neutral

Hindalco. CMP: INR113 TP: INR151 Buy

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral

CMP: INR415 TP: INR 471 BUY

Idea Cellular. CMP: INR159 TP: INR200 Buy

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy

Sandipan Pal QFY13 Results Update Sector: Real Estate Unitech CMP: INR29 TP: INR44 Buy

Cement. Demand to grow 8%, with cost push to be passed on CCI probe to have limited impact

Maruti Suzuki. CMP: INR1,395 TP: INR1,730 Buy

Raymond. Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy. CMP: INR385 TP: INR462 Buy

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat

Hindustan Unilever. CMP:INR324 TP:INR302 Neutral

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral

Godrej Properties. CMP: INR595 TP: INR635 Neutral

Siddharth Bothra

Dabur India. CMP: INR130 TP: INR135 Neutral

Cross service charges at INR m/quarter

Jinesh Gandhi Chirag Jain

Jinesh Gandhi Sandipan Pal

M&M Financial Services

Godrej Consumer Products

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

Sun Pharmaceuticals. CMP: INR554 TP: INR614 Neutral

Pantaloon Retail. CMP: INR177 TP: INR192 Neutral

Oberoi Realty. CMP: INR269 TP: INR320 Buy

Phoenix Mills. CMP: INR184 TP: INR255 Buy

Tribhovandas Bhimji Zaveri

Urban demand revives; Akzo gaining market share

Market share recovery, price hike, content leverage to drive growth

CMP: INR401 TP: INR516 Buy. * After ESOP charges; # Axon consolidated in December 2008

Coal India. CMP: INR322 TP: INR370 Buy

Shriram Transport Finance

Maruti Suzuki. CMP:Rs1,327 TP:Rs1,625 Buy

CPCB-2: Important long-term driver

Shree Renuka Sugars. CMP: INR41 TP: INR50 Buy

Stress test: Weak capital servicing ratios to drive pricing discipline

ITC. CMP: INR201 TP: INR230 Buy

Alpesh Mehta Sohail Halai

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

Jinesh Gandhi Chirag Jain

Birla Corporation. CMP: INR216 TP: INR277 Buy

Hardick Bora QFY13 Results Update Sector: Healthcare Lupin CMP: INR725 TP: INR851 Buy

Cummins India. Profitability supported by cost optimization measures. CMP: INR449 TP: INR432 Neutral

Godrej Consumer Products

Hardick Bora 4QFY13 Results Update Sector: Healthcare Dr Reddy's Laboratories CMP: INR2,026 TP: INR2,375 Buy

Shoppers Stop. CMP: INR339 TP: INR355 Neutral

Dabur India. Neutral. Rs93

Torrent Pharmaceuticals

Jinesh Gandhi Sandipan Pal

Punjab National Bank. CMP: INR760 TP: INR964 Buy Asset quality deteriorates; asset-liability well-matched Highlights of FY12 Annual Report

Godrej Properties. CMP: INR368 TP: INR420 Neutral

Jinesh Gandhi Sandipan Pal

Reliance Communications

Previous Recommendation: Neutral

Previous Recommendation: Buy

Just Dial. CMP: INR1,129 TP: INR1,475 Buy

Transcription:

BSE SENSEX S&P CNX 16,216 4,908 Bloomberg LT IN Equity Shares (m) 608.9 52-Week Range (INR) 1,868/971 1,6,12 Rel. Perf. (%) -4/-7/12 M.Cap. (INR b) 706.3 M.Cap. (USD b) 13.1 * Consolidated; EPS is fully diluted 15 May 2012 4QFY12 Results Update Sector: Capital Goods Larsen & Toubro CMP: INR1,160 TP: INR1,417 Buy 4QFY12 operational performance in line: Larsen and Toubro (LT) reported revenue growth of 21% YoY and EBITDA growth of 9% YoY for 4QFY12, largely in line with our estimates. PAT grew 22% YoY, higher than our estimate, supported by higher other income, lower interest and lower tax rates. Missed FY12 order intake guidance; EBITDA margin in line: In 4QFY12, order intake was INR212b, down 30% YoY. In FY12, order intake was INR706b, down 12%; the management had guided 5% growth. LT is seeing meaningful increase in order contribution from the Infrastructure segment while the share of Oil & Gas has declined significantly in the last two years. The contribution from overseas orders has also increased meaningfully. In FY12, E&C margins declined 95bp to 12.7% v/s management guidance of 75-125bp decline. Management guidance for FY13 a positive surprise: The management has guided 15-20% growth in order intake and revenue for FY13, and EBITDA margin within 50bp of FY12 level. Order intake of INR805b-840b in FY13 will be supported by INR120b-150b of project deferments in FY12, increase in contribution of international markets from 18% in FY12 to 25%, steady contribution of ~20% from the Buildings & Factories, Oil & Gas and Process Industries. Standalone profit to remain flat YoY; manufacturing JVs to impact consolidated profit: We expect standalone EPS (net of dividend from subsidiaries) to remain flat at INR67/INR68 for FY13/14 v/s INR67 in FY12. Revenue would grow at a CAGR of 10% while EBITDA margin would decline by 72bp over FY12-14. We estimate consolidated EPS at INR87 (+12%, upgrade of 5%) for FY13 and at INR89 (+2%, downgrade of 4%) for FY14. There exist headwinds to consolidated numbers, given poor business visibility for manufacturing JVs like Power BTG, Shipbuilding and Forgings, and investment in BOT projects. Our estimates do not fully capture the possible impact of capacity under-utilization in the initial periods. Maintain Buy with an SOTP-based target price of INR1,417. We value LT standalone at 14x FY14E earnings and subsidiaries at INR428/share. Satyam Agarwal (AgarwalS@MotilalOswal.com); +91 22 39820 5410 Deepak Narnolia (Deepak.Narnolia@MotilalOswal.com); +91 22 3029 5126

4QFY12 operational performance in line LT reported revenue growth of 21% YoY and EBITDA growth of 9% YoY for 4QFY12, largely in line with our estimates. PAT grew 22% YoY, higher than our estimate, supported by higher other income, lower interest and lower tax rate. Interest expense at INR1.2b was lower than our estimate of INR2.2b, led by better liquidity management, repayment of high cost debt and packing credit in foreign currency. Tax rate was 26.9% in 4QFY12 v/s our estimate of 38%. EBITDA margin declined 150bp YoY, impacted by increase in raw material cost, which increased by 230bp YoY as a percentage of sales. While staff cost was flat YoY, SG&A expenses were down 120bp YoY and other manufacturing expenses declined 40bp YoY. 4QFY12 revenue up 21% YoY; execution healthy EBITDA margin down 150bp YoY Missed FY12 order intake guidance; expect 15-20% growth in FY13 Missed FY12 order intake guidance: In 4QFY12, order intake was INR212b, down 30% YoY. In FY12, order intake was INR706b, down 12%; the management had guided 5% growth. Order intake was impacted by slowdown in the Power segment and sluggish industrial capex. In the Power segment, order intake declined 42%, while in Process Industries, order intake declined 39% YoY. The Oil & Gas segment witnessed strong order growth on a low base and Infrastructure segment orders grew 12%. Order intake (INR b) impacted by order deferments Order book to bill (BTB x) at 2.7x TTM 15 May 2012 2

Contribution of export orders doubled: Export orders in the E&C segment grew 2x to INR113b and the contribution from exports has almost doubled in FY12. In the domestic market, E&C orders declined 22%. Meaningful change in order mix LT is seeing a meaningful increase in contribution of orders from the Infrastructure segment while the share of the Oil & Gas segment has significantly declined over the last two years. The Infrastructure segment contributed 48% of the intake v/s 38% in FY11 and 27% in FY10. The share of Oil & Gas declined to 10% from ~15% over the past three years and 20-25% prior to that. The contribution from overseas orders has also increased meaningfully. Overseas markets contributed 18% of the order intake in FY12, v/s 10% in FY11 and 5% in FY10. Order intake composition: Increased share of Infra/Power segments, lower contribution of Oil & Gas adverse for margins (%) Contribution from export to order intake doubled over last two years E&C segment revenue grew 22% YoY, margins in line with guidance E&C segment revenue grew 22% YoY while EBITDA margin declined 120bp YoY during the quarter. For FY12, EBITDA margin decline was in line with the management guidance of 75-125bp reduction. 15 May 2012 3

Net working capital rises to 12% of sales from 8% in 4QFY11 NWC increased to 12% of revenue in 4QFY12 from 8% in 4QFY11. We expect NWC of 13-15% in the long term. This led to lower operating cash flows at INR11b v/s INR38b in 4QFY11. Gross debt on the book increased to INR99b from INR86b as at 2QFY12. Cash in hand stands at INR87b, down from INR90b in March 2011. Balance Sheet (INR b) Standalone Consolidated FY12 FY11 FY12 FY11 Net Worth 252.2 218.5 311.4 260.8 Long Term Liabilities 61.1 59.6 416.9 301.2 Total Capital Employed 313.4 278.1 728.3 561.9 Fixed Assets 83.6 74.2 343.1 279.9 Non current investments 90.8 74.0 15.6 15.0 Other Non Current Assets 41.7 33.2 189.8 126.6 Total Non Current Assets 216.2 181.3 548.6 421.5 Current Assets 459.7 389.8 641.4 525.8 Current Liabilities 363.6 293.0 461.6 385.4 Net Current Assets 96.2 96.8 179.7 140.4 Total Assets 312.4 278.1 728.3 561.9 Subsidiaries' performance robust For FY12, L&T Infotech reported 29% growth in revenue while PAT grew 33%. Growth in revenue came primarily from North American markets and INR depreciation. This is encouraging, as profit margins were impacted by the expiry of STPI tax benefits. L&T Finance Holdings reported revenue growth of 42% and PAT growth of 16%. 15 May 2012 4

Subsidiary performance (INR m) L&T Infotech 1QFY10 2QFY10 3QFY10 4QFY10 1QFY11 2QFY11 3QFY11 4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 Sales (INR m) 4,730 4,690 5,120 4,570 5,670 5,890 6,010 7,010 7,380 7,760 8,350 8,170 Growth (%) 4.6 (17.3) (2.3) (8.4) 19.9 25.6 17.4 53.4 30.2 31.7 38.9 16.5 PAT 610 570 730 900 750 760 710 940 900 1,030 1,160 1,100 Growth (%) - (29.6) 23.7 38.5 23.0 33.3 (2.7) 4.4 20.0 35.5 63.4 17.0 Net Profit Margin (%) 12.9 12.2 14.3 19.7 13.2 12.9 11.8 13.4 12.2 13.3 13.9 13.5 L&T Finance Holdings (NBFCs) (INR m) 4QFY12 4QFY11 FY12 FY11 YoY (%) 4QFY12 FY12 Loans and Advances 254,420 182,430 254,420 182,430 39.5 39.5 Total Income 8,520 6,030 30,070 21,170 41.3 42.0 PAT 1,390 1,110 4,660 4,320 25.2 7.9 NIM (%) 6.0 6.6 5.4 6.8 Gross NPA (%) 1.8 1.1 1.8 1.1 Credit Losses (%) 0.7 0.8 0.9 1.2 L&T Finance Holdings (PAT) 1,410 970 4,550 3,910 45.4 16.4 Average Net Worth 38,230 26,190 38,230 26,190 46.0 46.0 Valuation and view We expect standalone profits (net of dividend from subsidiaries) to remain flat over the next two years. Manufacturing JVs would have a negative impact on consolidated profits. Dividend income from subsidiaries was INR4.1b in FY12 (v/s INR2.3b in FY11); adjusted for this, standalone EPS for FY12 was INR67 (up 11%). We expect standalone EPS (net of dividend from subsidiaries) to remain flat at INR67/INR68 for FY13/14 v/s INR67 in FY12. Revenue would grow at a CAGR of 10% while EBITDA margin would decline by 72bp over FY12-14. We estimate consolidated EPS at INR87 (+12%, upgrade of 5%) for FY13 and at INR89 (+2%, downgrade of 4%) for FY14. There exist headwinds to consolidated numbers, given poor business visibility for manufacturing JVs like Power BTG, Shipbuilding and Forgings, and investment in BOT projects. Our estimates do not fully capture the possible impact of capacity under-utilization in the initial periods. Maintain Buy with an SOTP-based target price of INR1,417. We value LT standalone at 14x FY14E earnings and subsidiaries at INR428/share. 15 May 2012 5

Larsen & Toubro: an investment profile Company description L&T is India's largest engineering and construction company. Apart from its core construction activity the company is making significant inroads into diverse range of products & services through its subsidiaries and manufacturing JVs in Power BTG, forging and shipbuilding. The company is also involved in various developmental projects on BOT basis in roads, ports, rails and power projects. Export contributes to around ~18% of the order intake. Key investment arguments L&T is well placed to capitalize on long-term infrastructure demand. L&T's order backlog is worth INR1458b implying BTB ratio of 2.7x TTM. We believe L&T is the best play on capex with its strong execution skills, diversified portfolio and strong balance sheet and will benefit from a likely pick up in demand. L&T's operational performance continues to be encouraging in a challenging environment. Revenue growth is robust, with management guiding for FY13 growth at 15-20%, on back of 21% growth in FY12. Margins have again shown some stability, given the premium positioning and various cost optimization / productivity enhancement measures being undertaken. Order intake is also expected to be steady with management guidance for 15-20% growth, despite a challenging macro environment. Comparative valuations L&T BHEL Thermax P/E (x) FY13E 13.3 8.5 14.2 FY14E 13.1 11.0 12.6 P/BV (x) FY13E 2.5 1.8 2.7 FY14E 2.2 1.7 2.4 EV/Sales (x) FY13E 1.3 1.0 0.8 FY14E 1.2 1.1 0.7 EV/EBITDA (x) FY13E 11.3 5.2 8.1 FY14E 11.0 6.7 7.1 Key investment concerns Order intake is driven by long gestation projects and is unlikely to favorably impact FY13 revenues and margins. Also key investments in manufacturing JVs and BOT projects are likely to be a drag on profits in the near term; impacting RoEs. An unfavorable political climate, logjams relating to clearances for projects stifle fresh order intake growth, hampering earnings growth. Recent developments In a long-awaited management succession exercise, L&T announced appointment of Dr. K Venkatramanan as its new CEO and Managing Director, while its current CMD, Mr. A M Naik would continue as the Executive Chairman for the next five years. L&T has lost to competitors in the NTPC bulk tenders 1 & 2 worth INR390b with nil orders. This is a significant loss given the tenders were expected to be important drivers for growth in BTG JV. Valuation and view On our estimates standalone revenues would grow at a CAGR of 10% while EBITDA margins would decline by 72bp over FY12-14. We estimate consolidated FY13 EPS at INR87 (+12%, upgrade of 5%) / FY14 at INR89/sh (+2%, downgrade of 4%). Maintain Buy with a SOTP-based TP of INR1,417/sh. Sector view We maintain our Neutral view on the sector EPS: MOSL forecast v/s consensus (INR) MOSL Consensus Variation Forecast Forecast (%) FY13 87.4 86.2 1.4 FY14 88.6 96.7-8.4 Target price and recommendation Current Target Upside Reco. Price (INR) Price (INR) (%) 1,160 1,417 22.2 Buy Stock performance (1 year) Shareholding pattern (%) Mar-12 Dec-11 Mar-11 Promoter 0.0 0.0 0.0 Domestic Inst 36.6 37.8 37.5 Foreign 19.7 17.9 19.6 Others 43.7 44.3 42.9 15 May 2012 6

Financials and Valuation 15 May 2012 7

Disclosures This report is for personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement Larsen & Toubro 1. Analyst ownership of the stock No 2. Group/Directors ownership of the stock No 3. Broking relationship with company covered No 4. Investment Banking relationship with company covered No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. MOSt is not a registered broker-dealer in the United States (U.S.) and, therefore, is not subject to U.S. rules. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., Motilal Oswal has entered into a chaperoning agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo"). This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, Marco Polo and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. Motilal Oswal Securities Ltd 3rd Floor, Hoechst House, Nariman Point, Mumbai 400 021 Phone: (91-22) 39825500 Fax: (91-22) 22885038. E-mail: reports@motilaloswal.com